6 people in the Netherlands with monkeypox There are now 6 cases of monkeypox in humans in the Netherlands. Science Photo Library / ANP
First patient with monkeypox in the Netherlands This afternoon, a patient with monkeypox was confirmed in the Netherlands for the first time. RIVM researchers confirmed that the person has monkeypox with a PCR test. Science Photo Library / ANP
Even after COVID-19 crisis, social isolation continues Even after most coronavirus measures have been discontinued, some people are still living in social isolation to avoid COVID-19 exposure.
Decrease in SARS-CoV-2 hospital admissions, fewer people tested 1,214 patients with a SARS-CoV-2 infection were admitted to hospital in the Netherlands in the past week*, a decrease of 12% compared to the week before that.
New WHO Collaborating Centre hosted by RIVM combines laboratory preparedness and biorisk RIVM has been designated WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk by the World Health Organization (WHO).
Zoonoses Report 2020 focuses on emerging zoonoses The COVID-19 pandemic and the outbreak of the West Nile Virus in 2020 show that so-called emerging zoonoses pose a risk to the Netherlands. ANP
European project COHESIVE develops sustainable One Health approaches Today, fellow scientists and policymakers join the end symposium of the international project COHESIVE: One Health Structures in Europe.
Levels of salt, saturated fat, and sugar in most foods has remained the same or decreased The levels of salt, saturated fat, and sugar in most processed foods has remained the same or decreased since 2018.
More hospital admissions, decrease in positive COVID-19 tests The number of new patients admitted to hospital with COVID-19 increased to 538 admissions last week. That is 266 more admissions than in the previous week.
Increase in hospital admissions, cautious stabilisation in positive COVID-19 tests In the past week from 14-20 July 2021, the reported number of people who tested positive for COVID-19 increased by 34% compared to the previous week.